Pneuma Systems Corporation
Pneuma Systems Corporation specializes in designing and licensing closed-loop fluid control systems that precisely manage small fluid volumes without the complexity of traditional pumping mechanisms. The company leverages over 30 inventions and three novel subsystems to revolutionize fluid flow, workflow, information flow, and cash flow, aiming to transform the standard of care in infusion therapy.
Industries
Nr. of Employees
small (1-50)
Pneuma Systems Corporation
111 Bow Street, Suite 6, Portsmouth, NH 03801
Products
Infusion controller and administration set platform (in development)
Integrated controller and administration sets intended to provide closed-loop control of intravenous fluid delivery and to maintain therapy continuity across care settings.
Administration sets and container interfaces (collaboration)
Administration sets and delivery-system interfaces developed in collaboration with medication container and delivery-system suppliers to improve patient experience and device compatibility.
Infusion controller and administration set platform (in development)
Integrated controller and administration sets intended to provide closed-loop control of intravenous fluid delivery and to maintain therapy continuity across care settings.
Administration sets and container interfaces (collaboration)
Administration sets and delivery-system interfaces developed in collaboration with medication container and delivery-system suppliers to improve patient experience and device compatibility.
Services
Design, development, and licensing of closed-loop fluid control subsystems and inventions for clinical and laboratory fluid handling.
Development of integrated infusion controller and administration set platforms intended to maintain therapy continuity during patient transfers.
Support for regulatory planning and engagement with accelerated review programs to expedite device assessment and market access.
Design and execution of reliability engineering, failure-mode testing, and post-market surveillance programs to monitor device safety and performance.
Consulting to redesign infusion workflows, reduce nursing non-clinical tasks, and implement Centers of Infusion Excellence.
Structured programs to collect clinical and patient input for device design and usability improvements.
Design, development, and licensing of closed-loop fluid control subsystems and inventions for clinical and laboratory fluid handling.
Development of integrated infusion controller and administration set platforms intended to maintain therapy continuity during patient transfers.
Support for regulatory planning and engagement with accelerated review programs to expedite device assessment and market access.
Design and execution of reliability engineering, failure-mode testing, and post-market surveillance programs to monitor device safety and performance.
Consulting to redesign infusion workflows, reduce nursing non-clinical tasks, and implement Centers of Infusion Excellence.
Structured programs to collect clinical and patient input for device design and usability improvements.
Expertise Areas
- Closed-loop infusion device development
- Infusion therapy workflow optimization
- Reliability engineering and device diagnostics
- Regulatory strategy for medical devices (including accelerated pathways)
Key Technologies
- Closed-loop flow control
- Microfluidic/low-flow delivery methods
- Embedded device software and firmware
- Device self-diagnostics and failure-mode detection
News & Updates
Pneuma Systems Corporation's infusion system has been added to the FDA's Safer Technologies Program (STeP), which accelerates regulatory review for medical devices offering significant advantages over current options.
ECRI's list identifies potential sources of danger in health technology, with a focus on infusion pumps, and offers recommendations for reducing risks.
The 9th Edition calls for standardizing pump types within organizations to promote user familiarity and minimize re-establishing infusions after patient transfers.
Pneuma Systems Corporation's infusion system has been added to the FDA's Safer Technologies Program (STeP), which accelerates regulatory review for medical devices offering significant advantages over current options.
ECRI's list identifies potential sources of danger in health technology, with a focus on infusion pumps, and offers recommendations for reducing risks.
The 9th Edition calls for standardizing pump types within organizations to promote user familiarity and minimize re-establishing infusions after patient transfers.